Your AI-Trained Oncology Knowledge Connection!

Optimizing CTCL Care: Expert Perspectives on Patient-Centered Approaches

home / peer-exchange / optimizing-ctcl-care-expert-perspectives-on-patient-centered-approaches

David C. Fisher, MD; Lauren C. Pinter-Brown, MD; Barbara Pro, MD, and Sima Rozati, MD, PhD discuss how to optimize cutaneous T-cell lymphoma treatment through multidisciplinary care, compartment-specific therapy selection, management of treatment-related complications like mogamalizumab-associated rash, and strategic use of combination therapies while addressing critical unmet needs including biomarker development and improved quality of life measures.

EP. 1: Cutaneous T-Cell Lymphoma Insights: Distinguishing MF and SS, and Recognizing Early-Stage Clues

By David C. Fisher, MD
Lauren C. Pinter-Brown, MD,

June 4th 2025

Panelists discuss how CTCL is diagnosed, distinguished between Mycosis Fungoides and Sézary Syndrome, and why early-stage disease is often misdiagnosed due to its resemblance to benign skin conditions.

EP. 2: Understanding CTCL Staging: From Limited Mycosis Fungoides to Advanced Disease

By David C. Fisher, MD
Lauren C. Pinter-Brown, MD,

June 4th 2025

Panelists discuss how early-stage CTCL is defined using TNMB staging criteria, the typical presentation of patients at various stages, and the implications for treatment approaches.

EP. 3: Managing Early-Stage Mycosis Fungoides: Treatment Goals and Topical Therapy Selection

By David C. Fisher, MD
Lauren C. Pinter-Brown, MD,

June 10th 2025

Panelists discuss how therapeutic goals for early-stage CTCL focus on symptom control with skin-directed therapies, avoiding systemic chemotherapy due to long-term toxicity and poor outcomes.

EP. 4: Collaborating With Dermatologists: Coordinating Skin-Directed Therapy and Follow-Up in CTCL

By David C. Fisher, MD
Lauren C. Pinter-Brown, MD,

June 10th 2025

Panelists discuss how multidisciplinary collaboration between dermatologists and oncologists helps optimize personalized treatment plans by integrating skin-directed and systemic therapies.